GlaxoSmithKline logo

Corporate Responsibility Report 2008

Public policy activity in 2008

We engage with governments and other stakeholders on a wide range of issues that affect our industry.

These are some of the key issues we engaged on during 2008:

We publish our position on key issues relating to corporate responsibility, including:

  • Access to medicines in developing countries
  • Research and development
  • Intellectual property
  • The environment
  • Public health
  • Competitiveness
  • Pricing, reimbursement and market access

We are happy to discuss our position on these or any other issues with legitimate parties. Contact our corporate responsibility team at csr.contact@gsk.com.